Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer’s Disease and Dementia with Lewy Bodies

Neuropathologic Findings of Dementia with Lewy Bodies (DLB) in a Population-based Vantaa 85+ Study

(2017) Minna Oinas et al.   JOURNAL OF ALZHEIMERS DISEASE

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease

(2015) Aline Dorey et al.   Frontiers in Neurology

Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein

(2014) Mutsumi Mizoi et al.   CLINICA CHIMICA ACTA

Does CSF p-tau181 help to discriminate Alzheimer’s disease from other dementias and mild cognitive impairment? A meta-analysis of the literature

(2014) Wei Tang et al.   JOURNAL OF NEURAL TRANSMISSION

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus

(2014) N. R. Graff-Radford   NEUROLOGY

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

(2014) Paul C Donaghy et al.   Alzheimers Research & Therapy

Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

(2013) Yaroslau Compta et al.   PARKINSONISM & RELATED DISORDERS

Alterations of CSF Cystatin C Levels and Their Correlations with CSF Αβ40 and Αβ42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis

(2013) Xiao-Mei Zhong et al.   PLoS One

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

(2012) Jan Jessen Krut et al.   JOURNAL OF NEUROLOGY

Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT

(2012) Shirlony Morgan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurochemical biomarkers in Alzheimer’s disease and related disorders

(2012) Mirko Bibl et al.   Therapeutic Advances in Neurological Disorders

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Prevalence and Pathology of Dementia with Lewy Bodies in the Oldest Old: A Comparison with Other Dementing Disorders

(2011) Kurt A. Jellinger et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Aβ Accelerates the Spatiotemporal Progression of Tau Pathology and Augments Tau Amyloidosis in an Alzheimer Mouse Model

(2010) David E. Hurtado et al.   AMERICAN JOURNAL OF PATHOLOGY

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

(2010) Niklas Mattsson et al.   BMC Neurology

The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia

(2010) P.E. Spies et al.   Current Alzheimer Research

Differential levels of  -synuclein,  -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

(2010) K. Kasuga et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography

(2010) David J. Brooks   MOVEMENT DISORDERS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study

(2009) Jennifer Molano et al.   BRAIN

Low sensitivity in clinical diagnoses of dementia with Lewy bodies

(2009) Peter T. Nelson et al.   JOURNAL OF NEUROLOGY

Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease

(2008) G.A. Jicha et al.   NEUROBIOLOGY OF AGING